Danish company NNE Pharmaplan is preparing modular vaccine facility concepts
Danish company NNE Pharmaplan is preparing modular vaccine facility concepts. Modular vaccine facilities offer the ability to fast-track projects and reduce investment.
The concepts are based on ‘biotypes’ for facilities that handle live seed stocks of infectious agents – similar to the phenotypic classification principles for bacteria and viruses. Facility biotype integrates biosafety levels for infectious agents, background processing of cleanrooms, process unit operations and architectural modularity. It also offers the flexibility to expand.
NNE Pharmaplan says it focuses on: generalising the overall layout for a particular type of process or facility; using flexible and single-use equipment; and enclosing the process as much as possible. This ensures fewer high classification cleanrooms and cuts use of utilities such as WFI, while still providing the necessary capacity.
‘We fabricate the modules in low-cost countries, and lower the design and layout cost by simply adding or subtracting individual modules and functions,’ says the company.